Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
30.9M
-
Number of holders
-
142
-
Total 13F shares, excl. options
-
28M
-
Shares change
-
+312K
-
Total reported value, excl. options
-
$1.47B
-
Value change
-
+$16.9M
-
Put/Call ratio
-
0.16
-
Number of buys
-
72
-
Number of sells
-
-56
-
Price
-
$52.47
Significant Holders of CONMED Corp - Common Stock (CNMD) as of Q3 2017
161 filings reported holding CNMD - CONMED Corp - Common Stock as of Q3 2017.
CONMED Corp - Common Stock (CNMD) has 142 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28M shares
of 30.9M outstanding shares and own 90.72% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.2M shares), SCOPIA CAPITAL MANAGEMENT LP (2.77M shares), VANGUARD GROUP INC (2.34M shares), DIMENSIONAL FUND ADVISORS LP (2.23M shares), VICTORY CAPITAL MANAGEMENT INC (2.18M shares), Champlain Investment Partners, LLC (1.66M shares), Capital World Investors (1.11M shares), CRAMER ROSENTHAL MCGLYNN LLC (1.03M shares), GOLDMAN SACHS GROUP INC (1.01M shares), and Capital Research Global Investors (881K shares).
This table shows the top 142 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.